The analysis is among the first to measure the direct costs created by the import taxes on employers with $10 million to $1 billion in annual revenue.

A discussion about innovation in product development and the supply chain, with Joe Bitterman, VP supply chain planning with Johnson & Johnson Innovative Medicine, and Philip Vervloesem, chief commercial officer with OMP.

Michael Halaiko and Alex Moylan, shareholders in the law firm of Baker Donelson, discuss the Trump Administration’s recent executive orders on domestic production of critical medicines.

According to a March 2025 survey of 200 health care industry experts, 82% said that they expect tariff-related expenses to raise hospital costs by up to 15% over the next six months.

Large language models are enhancing decision-making, automating routine tasks and improving efficiency across procurement, logistics, inventory management and supplier collaboration.

Immigration and Customs Enforcement has arrested tens of thousands of people living in the U.S. without legal status since January, when Trump took office.

The agreement includes provisions for the rapid sharing of data about new diseases, to ensure scientists and pharmaceutical companies can work more quickly to develop treatments and vaccines

Most companies said bringing back supply chains within the U.S. could as much as double their costs, and it would be more cost-effective to relocate them to lower-tariffed countries.

Even balanced against elevated levels earlier this year, total 2025 cargo volume could show a net decline of 15% or more unless the situation with tariffs changes.

If anything, Trump's delay in some of his tariff plans is extending the uncertainty that has already begun to drag on business and consumer sentiment.